Markets
Borrow
Earn
Invest
Private
Security
Newsroom
More
Log In
Sign Up
Markets
Market Overview
Indices and commodities.
Digital Credit
Bitcoin treasury preferreds.
AI Stocks
The artificial intelligence theme.
Bitcoin Treasuries
Companies holding bitcoin.
Economy
Sectors, global markets and rates.
Popular Portfolios
13F filings, smart money.
Borrow
Borrow
Borrow USDT or USDC against your BTC without giving it up.
ReFi
Switch your bitcoin-backed loan and pay less interest.
Earn
Carry Trade
Borrow, invest, keep the spread.
Stock Dividends
Dividends from tokenized equities.
Invest
Private
Security
Newsroom
More
Company
About Us
Our leadership team, mission, and investors.
Whitepaper
Vision, purpose, and architecture behind Roxom.
Legal
Terms, privacy, and disclosures.
Resources
Help Center
Guides, FAQs & support.
Rulebook
Trading logic, platform rules, and fundamentals.
API Docs
Connect, authenticate, and build with our API.
Status
Current platform health and incidents.
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
1 BTC
=
- USD
BTC
SATS
Loading market data...
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
RD
Redhill Biopharma Ltd.
RDHL
Mkt Cap
$4.4M
Volume
84.72K
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
RD
RDHL
RD
Redhill Biopharma Ltd.
RDHL
News
·
Nontuberculous Mycobacterial Infections Market to Showcase Growth at a CAGR of 12.6% During the Forecast Period (2026–2036), Driven by Rising Disease Burden and Emerging Therapies | DelveInsight
Mkt Cap
$4.4M
Volume
84.72K
Next Earnings
N/A
Chart
Earnings
News
About
Insider
Filings
Nontuberculous Mycobacterial Infections Market to Showcase Growth at a CAGR of 12.6% During the Forecast Period (2026–2036), Driven by Rising Disease Burden and Emerging Therapies | DelveInsight
The nontuberculous mycobacterial (NTM) infections market is projected to grow at a CAGR of 12.6% from 2026-2036, valued at USD 750 million in 2025. Growth is driven by rising disease prevalence, improved diagnostics, and emerging therapies including Omadacycline (NUZYRA), MRX-5, Epetraborole, and RHB-204. The US represents the largest market with approximately 400,000 diagnosed NTM cases across the 7MM countries.
GlobeNewswire Inc. · Aug 31, 2026
RedHill Biopharma Receives Nasdaq Staff Determination Notification
RedHill Biopharma received a Nasdaq Staff Determination letter indicating non-compliance with minimum stockholders' equity requirements. The company plans to appeal the determination and believes its recent transaction with Cumberland Pharmaceuticals has improved its equity position.
Benzinga · Oct 22, 2025
Nasdaq Edges Lower; American Airlines Posts Upbeat Earnings
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite turning lower on Thursday. The Dow traded up 0.25% to 37,900.45 while the NASDAQ fell 0.13% to 15,462.53. The S&P 500 also rose, gaining, 0.19% to 4,877.88. Check This Out: How To Earn $500 A Month From Capital One Financial Ahead Of Its Q4 Earnings Report Leading and Lagging Sectors Energy shares rose by 1.7% on Thursday. In trading on Thursday, consumer discretionary shares fell by 1.5%. Top Headline American Airlines Group Inc (NASDAQ: AAL) reported better-than-expected fourth-quarter results. American Airlines reported a 75% drop in adjusted earnings to 29 cents per share in the fourth quarter of 2023 but still came in well above the consensus estimate of 10 cents per share. Total revenue decreased 1% to $13.06 billion, just beating estimates of $13.02 billion. American Airlines expects its full-year 2024 adjusted earnings per diluted share of $2.25-$3.25 versus the consensus of $2.25. Equities Trading UP Vera Therapeutics, Inc. (NASDAQ: VERA) shares shot up 53% to $25.97 after the company announced 72-week data from the OLE period of its Phase 2b ORIGIN clinical trial. Also, Oppenheimer initiated coverage on the stock with an Outperform rating and announced a $26 price target. Shares of Processa ...
Benzinga · Jan 25, 2024
Why Humana Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Humana Inc. (NYSE: HUM) fell sharply during Thursday’s session after the company reported fourth-quarter FY23 earnings and issued 2024 guidance. The company reported a Q4 adjusted loss of 11 cents per share, a turnaround from EPS income of $1.97 per share a year ago, missing the consensus for a loss of 5 cents per share. The insurer reported adjusted revenue of $25.73 billion, compared to $21.30 billion a year ago and the consensus of $25.55 billion. Humana shares dipped 11.3% to $356.93 on Thursday. Here are some other stocks moving in today's mid-day session. Gainers Onconetix, Inc. (NASDAQ: ONCO) shares surged 137% to $0.3519 after falling over 4% on Wednesday. Processa Pharmaceuticals, Inc. (NASDAQ: PCSA) gained 97% to $4.0527 after the company announced the completion of the safety tolerability evaluation in its Phase 1b trial of Next Generation Capecitabine. Enviva Inc. (NYSE: EVA) climbed 47.4% to $0.5239. Vera Therapeutics, Inc. (NASDAQ: VERA) shares jumped 46% to $24.84 after the company announced 72-week data from the OLE period of its Phase 2b ORIGIN clinical trial. Also, Oppenheimer initiated coverage on the stock with an Outperform rating and announced a $26 price target. Rail Vision Ltd. (NASDAQ: RVSN) gained 43.8% to $7.78. Foresight's affiliate Rail Vision's Main Line System secured EU Railway Standards approval and certifications. LAVA Therapeutics N.V. (NASDAQ: LVTX) rose 37.4% to $2.13 after the company announced a clinical trial collaboration and supply agreement with Merck & Co. to evaluate LAVA-1207 in combination with KEYTRUDA. Acutus Medical, Inc. (NASDAQ: AFIB) shares climbed 30.6% to $0.29. Acutus Medical has been granted European patent number EP3043701 titled "Devices and Methods for Determination of Electrical Dipole Densities on a Cardiac Surface (And Methods for Diagnosing Tissue Health)." Prairie Operating Co. (NASDAQ: PROP) gained 28.8% to $8.17. American Superconductor Corporation (NASDAQ: AMSC) shares climbed 28.4% to $12.52 after the company reported better-than-expected third-quarter financial results and issued fourth-quarter revenue guidance above estimates. CCSC ...
Benzinga · Jan 25, 2024
Crude Oil Rises 2%; Tesla Shares Plunge After Downbeat Results
U.S. stocks traded slightly higher midway through trading, with the Nasdaq Composite gaining around 0.2% on Thursday. The Dow traded up 0.06% to 37,829.32 while the NASDAQ rose 0.22% to 15,515.62. The S&P 500 also rose, gaining, 0.26% to 4,881.28. Check This Out: How To Earn $500 A Month From Capital One Financial Ahead Of Its Q4 Earnings Report Leading and Lagging Sectors Communication services shares rose by 1.5% on Thursday. In trading on Thursday, consumer discretionary shares fell by 1.4%. Top Headline Tesla, Inc. (NASDAQ: TSLA) shares dipped more than 12% on Thursday after the company reported worse-than-expected fourth-quarter financial results. Tesla reported fourth-quarter revenue of $25.17 billion, which was up 3% year-over-year. The revenue missed a Street consensus estimate of $25.62 billion, according to data from Benzinga Pro. The company reported earnings per share of 71 cents, which missed a Street consensus estimate of 74 cents per share. Equities Trading UP Vera Therapeutics, Inc. (NASDAQ: VERA) shares shot up 40% to $23.87 after the company announced 72-week data from the OLE period of its Phase 2b ORIGIN clinical trial. Also, Oppenheimer initiated coverage on the stock with an Outperform rating and announced a $26 price target. Shares of Processa Pharmaceuticals, Inc. (NASDAQ: PCSA) got a boost, ...
Benzinga · Jan 25, 2024
Why BlackBerry Shares Are Trading Lower By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of BlackBerry Limited (NYSE: BB) fell sharply during Wednesday’s session after the company announced a proposed private offering of $160 million of convertible senior notes. BlackBerry shares tumbled 17.2% to $2.9387 on Wednesday. Here are some other stocks moving in today's mid-day session. Gainers Getaround, Inc. (NYSE: GETR) shares jumped 151.3% to $0.4618 after the company announced a new debt facility with Mudrick Capital Management for up to $20 million. Evaxion Biotech A/S (NASDAQ: EVAX) gained 94.4% to $9.70 after a 13G filing showed Merck & Co reported an 11.4% stake in the company as of Dec. 21, 2023. SciSparc Ltd. (NASDAQ: SPRC) shares gained 61.3% to $5.58 after the company revealed $20 million standby equity purchase agreement. Kura Oncology, Inc. (NASDAQ: KURA) rose 41.3% to $18.99. Kura Oncology announced oversubscribed $150 million private placement. Ensysce Biosciences, Inc. (NASDAQ: ENSC) shares jumped 32.2% to $1.8372. Ensysce Biosciences shares gained 22% on Tuesday after the company announced FDA Breakthrough Therapy Designation for PF614-MPAR. RedHill Biopharma Ltd. (NASDAQ: RDHL) climbed 25.5% to $1.1197. Redhill Biopharma was granted U.S. Patent #11878011 for "Method for Eradicating Helicobacter Pylori Infection in Patients Regardless of Body Mass Index." Purple Innovation, Inc. (NASDAQ: PRPL) gained 24% to $1.02 after the company announced it strengthened its balance sheet, creating greater financial flexibility to execute its ...
Benzinga · Jan 24, 2024
Why Netflix Shares Are Trading Higher By 10%; Here Are 20 Stocks Moving Premarket
Shares of Netflix, Inc. (NASDAQ: NFLX) shares rose sharply in today’s pre-market trading as the company reported better-than-expected sales for its fourth quarter. Netflix reported fourth-quarter revenue of $8.83 billion, which was up 12.5% year-over-year. The total came in ahead of a Street consensus estimate of $8.72 billion. The company reported fourth-quarter earnings per share of $2.11, which missed a Street consensus estimate of $2.21. The company, meanwhile, added 13.12 million net paid subscribers in the fourth quarter. Netflix shares jumped 10.2% to $542.48 in pre-market trading Here are some other stocks moving in pre-market trading. Gainers Getaround, Inc. (NYSE: GETR) gained 50.7% to $0.2771 in pre-market trading after the company announced a new debt facility with Mudrick Capital Management for up to $20 million. Evaxion Biotech A/S (NASDAQ: EVAX) gained 43.2% to $7.15 in pre-market trading after a 13G filing showed Merck & Co reported an 11.4% stake in the company as of December 21, 2023. VS MEDIA Holdings Limited (NASDAQ: VSME) shares jumped 31.7% to $0.4318 in ...
Benzinga · Jan 24, 2024
Why Steelcase Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Steelcase Inc. (NYSE: SCS) shares moved higher during Wednesday's session following quarterly results. Steelcase posted upbeat earnings for its third quarter, while sales missed estimates. The company said it sees fourth-quarter adjusted earnings of 19 cents to 23 cents per share on revenue of $765 million to $790 million. Steelcase shares gained 12.7% to $14.31 on Wednesday. Here are some other stocks moving in today's mid-day session. Gainers ParaZero Technologies Ltd. (NASDAQ: PRZO) climbed 86.4% to $1.3050. ParaZero successfully completed its drone safety project with a Fortune 500 leading automotive manufacturer. Polished.com Inc. (NYSE: POL) shares climbed 77.3% to $1.8794. Jerald Hammann, a Polished.com shareholder, urged shareholders concerned about their investment in Polished.com to collaborate to increase the effectiveness of their actions. Conduit Pharmaceuticals Inc. (NASDAQ: CDT) gained 35% to $5.65. Applied UV, Inc. (NASDAQ: AUVI) rose 29.5% to $2.38 after the company's recent announcement on successfully integrating its PURO and Airocide businesses into its Sterilumen subsidiary. Aclarion, Inc. (NASDAQ: ACON) shares rose 24.7% to $0.3650 after the company was granted U.S. patent #11844601 for "MR SPECTROSCOPY SYSTEM FOR DIAGNOSING PAINFUL AND NON-PAINFUL INTERVERTEBRAL DISCS (Severe Low Back Pain)." RedHill Biopharma Ltd. (NASDAQ: RDHL) gained 22.7% to $1.6197. RedHill and U.S. Army announced Opaganib and RHB-107 combinations with remdesivir show distinct synergistic effect against ebola. Canaan Inc. (NASDAQ: CAN) gained 20.8% to $2.6950. Sphere 3D Corp. (NASDAQ: ANY) rose 19.4% to $2.3300. Asset Entities Inc. (NASDAQ: ASST) shares gained 18% to $0.4599. Asset Entities recently announced the launch of Ternary V2, the next generation of Ternary’s Stripe-verified digital community payment processing platform. Applied UV, Inc.(NASDAQ: AUVI) gained 17.4% to $2.1502 after jumping around 21% on Tuesday. Applied UV recently announced successful integration of its PURO ...
Benzinga · Dec 20, 2023
Bill Gross says beaten-down mortgage plays may thrive — and offer huge yields
MarketWatch · Dec 1, 2023
Why Titan Machinery Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Titan Machinery Inc. (NASDAQ: TITN) moved lower during Thursday’s trading following weak quarterly results. Titan Machinery posted quarterly earnings of $1.32 per share, missing market estimates of $1.53 per share. The company’s quarterly sales came in at $694.12 million versus estimates of $727.20 million. Titan Machinery shares declined 8.1% to $23.41 on Thursday. Here are some other stocks moving in today's mid-day session. Gainers Minim Inc (NASDAQ: MINM) shares jumped 700% to $7.36 after gaining over 13% on Wednesday. AgriFORCE Growing Systems Ltd. (NASDAQ: AGRI) gained 174% to $2.47. Soligenix, Inc. (NASDAQ: SNGX) surged 116% to $0.90 after the company announced it received FDA IND clearance for the Phase 2 clinical trial of dusquetide in the treatment of aphthous ulcers of Behçet's disease. ImmunoGen, Inc. (NASDAQ: IMGN) shares jumped 80% to $28.89 after AbbVie announced it will acquire the company in a transaction valued at $31.26 per share in cash. Smart for Life, Inc. (NASDAQ: SMFL) gained 46% to $2.2221. Aditxt, Inc. (NASDAQ: ADTX) shares climbed 45% to $5.00. REX American Resources Corporation (NYSE: REX) gained 30.7% to $48.22 following strong third-quarter results. Clearmind Medicine Inc. (NASDAQ: CMND) rose 24.2% to $5.03 after surging 22% on Wednesday. Clearmind Medicine recently announced results from its weight loss and metabolic disorder program. Ucommune International Ltd (NASDAQ: UK) gained 21.8% to $6.58. Ampio Pharmaceuticals, Inc. (NASDAQ: AMPE) shares surged 21% to $2.3750 ...
Benzinga · Nov 30, 2023
Holdings
Open Orders (0)
Positions (0)
Order History
Dividends
Transfers
Log In
to start trading
RD
RDHL
Redhill Biopharma Ltd.
Buy
Sell
Market
Limit
Soon
RDHL
25%
50%
75%
Max
Pay with
—
Start Trading
Available Balance
0.00
Your Position
You don't own any RDHL yet.
Related Tickers
Earnings